Home › Bladder Cancer › Missouri › Columbia
Bladder Cancer clinical trials in Columbia, MO
4 studies for Bladder Cancer are looking for participants at sites in and around Columbia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
RecruitingPhase 2
- University of Missouri Health Care ( Site 0126), Columbia
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
RecruitingPhase 3
- Missouri Cancer Associates, Columbia
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
RecruitingPhase 3
- MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia
About Bladder Cancer
Bladder cancer symptoms range from lower back pain to blood in your urine. Read about important risk factors and find a list of treatments available
More about Bladder Cancer on MedlinePlus
Bladder Cancer trials in other cities
- New York City, NY35 studies
- Nashville, TN31 studies
- Houston, TX31 studies
- Dallas, TX27 studies
- Boston, MA26 studies
- Washington, DC26 studies
- Los Angeles, CA24 studies
- Baltimore, MD24 studies
- St. Louis, MO22 studies
- Philadelphia, PA21 studies
- Seattle, WA21 studies
- Edison, NJ21 studies
Other studies in Columbia
- Obesity12 studies
- Non-Small Cell Lung Cancer8 studies
- Colorectal Cancer7 studies
- Myasthenia Gravis6 studies
- Cancer (all types)6 studies
- Breast Cancer6 studies
- Type 2 Diabetes6 studies
- Lung Cancer5 studies
- Steatotic Liver Disease5 studies
- Cardiovascular Disease5 studies
- Heart Failure5 studies
- Insomnia4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.